Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Health Sciences

Rowan, Rutgers, Camden County College Partner on Health Sciences; Joint Health Sciences Center Construction Begins

Camden, NJ, October 18, 2017 — With a ceremonial groundbreaking on October 19, local, state and federal officials are joining with the Rowan University/Rutgers-Camden Board of Governors (Joint Board of Governors) to celebrate the beginning construction of the Joint Health Sciences Center, an innovative facility that will provide unique education and training opportunities to a new generation of health care providers.

Set to open in the spring of 2019 at the intersection of Martin Luther King Blvd. and Broadway in downtown Camden, the Joint Health Sciences Center will be the first of its kind in New Jersey.

The construction of the 95,000 square-foot building will generate approximately $72 million in economic impact in the City of Camden alone.  Continue reading

Rutgers Biomedical and Health Sciences Chancellor Leads an Institute of Medicine Committee Studying Viral Hepatitis

Brian StromNew Brunswick, NJ, December 17, 2015 ― Dr. Brian Strom, the chancellor of Rutgers Biomedical and Health Sciences, is heading a team of scientists who are trying to change the outlook for hepatitis patients.

Last month Strom was appointed to chair a committee selected by the National Academy of Sciences’ Institute of Medicine to determine whether eliminating HBV and HCV is feasible, and if so, to develop an action plan within the next few years.

Chronic viral hepatitis has a reputation for being a silent killer. The infection often goes undetected until the symptoms of advanced liver cancer appear. By that point, a patient has a five-year survival rate, according to the American Cancer Society. Continue reading

Seton Hall and Hackensack University Health Network to Open Medical School on Roche Property

Nutley, NJ, January 15, 2015 NJBIZ reports that Hackensack University Health Network and Seton Hall University today formally announced their plans to start the state’s first four-year, private medical school on the campus of the former Roche headquarters in Nutley and Clifton.

Alongside Seton Hall President A. Gabriel Esteban, Hackensack CEO and President Robert C. Garrett called the plan a “game-changer” and an “absolutely monumental event.” Continue reading

Rutgers to Host Biopharma, Health Care Innovation Leaders at North American Summit July 21-22

New Brunswick, NJ, July 15, 2014 — Rutgers, The State University of New Jersey will host the influential TTS Global Initiative’s North American Summit on July 21-22 at Rutgers’ Busch Campus in Piscataway, NJ.

The North American Summit is an annual meeting of top biotech VCs, bankers, biopharmaceutical and health care executives, technology-transfer and licensing directors with universities and institutes, biotech CEOs, and other key stakeholders in early-stage biotech and health care.

The event will offer participants the opportunity to network with peers and discuss the key issues, challenges, and opportunities facing all stakeholders in biopharma and health care innovation. Continue reading

Rutgers–Camden Adds Bachelor in Health Sciences Degree Program

Camden, NJ, June 30, 2014 — The New Jersey Council of Presidents has approved a bachelor of arts in health sciences degree program for the Rutgers University–Camden College of Arts and Sciences. Courses will begin in the fall.

The new 120-credit multi-disciplinary academic major will include courses in the general sciences while also educating students in subjects essential to modern health-related professions, such as behavioral therapy, biomedical ethics, health psychology, health advocacy, and human development.

The Rutgers University Board of Governors approved the new major in March.   Continue reading

Susan Dolbert Named VP of Development for Rutgers Biomedical and Health Sciences

New Brunswick, NJ, May 22, 2014 — Rutgers University Foundation President Nevin Kessler and Brian Strom, Chancellor, Rutgers Biomedical and Health Sciences, today announced Susan C. Dolbert has agreed to assume the post of vice president of development, Rutgers Biomedical and Health Sciences (RBHS).  She will join the foundation on September 2.

Dolbert’s responsibilities will include building a strong development program for RBHS, which consists of eight schools, including two medical schools, a school of nursing, a school of public health, a school of pharmacy, a graduate school of biomedical sciences, a school of dental medicine and a school of health related professions.

In addition to the schools, RBHS also includes the Cancer Institute of New Jersey; the Center for Advanced Biotechnology and Medicine; the Environmental and Occupational Health Sciences Institute; the Institute for Health, Health Care Policy and Aging Research; and University Behavioral Health Care. Continue reading

Rutgers Cancer Institute and Univ. of Wisconsin Carbone Cancer Center Awarded $4.25 Million Grant to Develop Innovative Clinical Trials

New Brunswick, NJ, March 21, 2014 — Precision medicine, or the movement to ‘personalize’ cancer treatments, has grown significantly over the past few years, with researchers from large universities and cancer centers from across the nation making advances in identifying targeted therapies and understanding what drives them.

Aiming to further build on that momentum with the development of innovative early-phase clinical trials examining genomic and therapeutic biomarkers is Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey.

Dr. DiPaola, who was just awarded a competitive $4.25 million grant (UM1CA186716) by the National Cancer Institute (NCI) of the National Institutes of Health to support the precision experimental therapeutics endeavor, will collaborate with investigators from the University of Wisconsin Carbone Cancer Center on the research that will have a nationwide reach. Continue reading

Rutgers to Host 2014 Rare Diseases Day Event on February 25

New Brunswick, NJ, February 6, 2014 ― You are invited to join Rutgers University for an event to celebrate and support individuals who have Rare Diseases on Tuesday, February 25 from 5 to 6:30 p.m. at both Newark and Piscataway Campuses. 

Rutgers Biomedical and Health Sciences (RBHS) Chancellor Brian Strom will be presenting opening remarks followed by several speakers.  Events will be held simultaneously and connected online. Continue reading

ACA Not a Cure-All for Patients with Rare Diseases, Experts Say

Somerset, NJ, December 12, 2013 ― Tom Zanki reports in NJBIZ that despite inroads made by the Affordable Care Act to improve prospects for people struggling with rare diseases, patient advocates say much work remains.

Better diagnosis and affordability top the list.

“It’s a really good starting point, but there are so many issues we still need to tackle,” Julie Raskin, co-chair of NJ Rare, an advocacy network for New Jersey’s rare disease population, said at a panel Wednesday at Forsgate Country Club in Monroe Township.

The panel was organized by the HealthCare Institute of New Jersey (HINJ) to brainstorm solutions for patients with rare disease, generally defined as disorders afflicting 200,000 or less people. There are about 7,000 such diseases, mostly genetic disorders. Continue reading

Rutgers Biomedical and Health Sciences Inaugural Chancellor Begins New Job

New Brunswick, NJ, December 6, 2013 ― In Dr. Brian Strom’s eyes, Rutgers Biomedical and Health Sciences (RBHS) has an opportunity that occurs rarely in higher education:  the chance to create “a perfectly shaped health care system” that serves an entire state, reports Jeff Tolvin. 

“We can create it for New Jersey,” Strom told an audience of faculty and staff gathered in Newark to welcome Strom on Monday, December 2, his first official day as the inaugural chancellor of Rutgers RBHS.

Strom, a renowned epidemiologist, award-winning teacher and clinician and longtime academic leader at the University of Pennsylvania, also met with faculty and staff in a similar “town hall” setting in Piscataway later that day. Continue reading